Molecular Templatesincis A Clinical Stage Biopharmaceutical Company That Focused On The Discovery And Development Of Biologic Therapeutics For Cancer And Other Serious Diseasesthe Company Developed Therapies Using Its Proprietary Engineered Toxin Bodyetbdrug Platformwhich Features Unique Mechanisms Of Action Distinct From Traditional Antibody Drug Conjugates The Company S Pipeline Included Several Etbs In Various Stages Of Clinical Trialssuch As Mt 6402 For Pd 1 Pd L1 Antibody Relapsed Refractory Conditionsmt 5111 For Her2 Positive Cancersand Mt 0169 For Relapsed Refractory Myelomaadditionallymolecular Templates Was Exploring Other Targetsincluding Ctla 4Tigittrop2And Bcmathe Company Also Had A Collaboration Agreement With Bristol Myers Squibb To Develop Novel Products Utilizing Etbs Directed At Multiple Targets
No conferences found for this company.
| Company Name | Molecular Templates Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
